The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway
Open Access
- 1 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (1) , 171-179
- https://doi.org/10.1182/blood-2007-02-071589
Abstract
The gene implicated in the May-Hegglin anomaly and related macrothrombocytopenias, MYH9, encodes myosin-IIA, a protein that enables morphogenesis in diverse celKeywords
This publication has 60 references indexed in Scilit:
- Proplatelet formation is regulated by the Rho/ROCK pathwayBlood, 2007
- Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2Blood, 2006
- RGS16 is a negative regulator of SDF-1–CXCR4 signaling in megakaryocytesBlood, 2005
- Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neuronsThe Journal of cell biology, 2003
- Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II InhibitorScience, 2003
- A lineage-restricted and divergent β-tubulin isoform is essential for the biogenesis, structure and function of blood plateletsCurrent Biology, 2001
- Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome)Blood, 2001
- ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparationPlatelets, 2000
- Identification of a Putative Target for Rho as the Serine-Threonine Kinase Protein Kinase NScience, 1996
- May-Hegglin Anomaly: A Defect in Megakaryocyte Fragmentation?British Journal of Haematology, 1974